Stephanie Fraley

Stephanie Fraley is a co-founder and scientific advisor at Melio. Stephanie was previously a BWF CASI postdoctoral research fellow at The Johns Hopkins School of Medicine, where they worked in emergency medicine and infectious disease. Stephanie has a passion for developing novel technologies that allow for the discrimination and quantification of mixed samples of nucleic acids. Her technologies also aim to measure the heterogeneity of a sample of nucleic acids and quantify each sequence individually. Stephanie's work is important for clinical and basic research applications, and their innovative approach to nucleic acid profiling has the potential to revolutionize diagnostics and biomarker research.

Stephanie Fraley has a Ph.D. in Chemical and Biomolecular Engineering from The Johns Hopkins University, and a B.S.E. in Chemical Engineering from The University of Tennessee at Chattanooga.